Generex Biotechnology Corporation
Generex Biotechnology Corporation (GNBT) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · GNBT · as of Jun 9, 2026
Key Statistics
Explore Generex Biotechnology Corporation Data
gnbt stock data · financialsFinancial Snapshot
Full FinancialsCompetitors & Peers
gnbt competitorsGNBT
ALEAF
CRXTQ
ENDP
HCLC
HGENQStock Performance
Full HistoryAbout Generex Biotechnology Corporation
Generex Biotechnology Corporation Founded in 1983 and headquartered in Miramar, Florida, Generex Biotechnology Corporation initially specialized in the delivery of large molecule drugs into the oral cavity via a portable aerosol appli…
what is generex biotechnology corporation · gnbt stock overview · generex biotechnology corporation company profile · who is generex biotechnology corporation ceo · gnbt OTC · generex biotechnology corporation headquarters · generex biotechnology corporation business segments
About Stock Overview & Key Data
Generex Biotechnology Corporation (GNBT) is a Healthcare company in the Biotechnology industry, listed on OTC since Feb 5, 1998. As of the latest trading session, GNBT stock price is $0.00, with a market capitalization of $0. The stock has returned -99.13% over the past 12 months and +0.00% year-to-date.
In fiscal year 2020, Generex Biotechnology Corporation reported revenue of $2.7M. For detailed financial data including revenue history, earnings, and balance sheet — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Generex Biotechnology Corporation (GNBT) stock price is $0.00. The stock is traded on OTC under the ticker symbol GNBT. The 52-week range is $1.00 – $4.00.